Investing Profile

Beth Seidenberg

VCInvestor

General Partner at Kleiner Perkins

kleinerperkins.com/people/bet...San Francisco, California
Photo of Beth Seidenberg, General Partner at Kleiner Perkins

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Kleiner Perkins General Partner
$2.0M - $50.0M
$25.0M
45
750M
CompanyStageDateRound SizeTotal Raised
Expansion Therapeutics
Series BSep 2021$80M
Series AJan 2018$55.3M
$135.3M
Co-investors: Scott Rocklage (5am Ventures), Andrew Levin (RA Capital)
Capsida
Series AApr 2021$50M
$50M
Sagimet Biosciences
Venture RoundFeb 2021$80M
Series EAug 2019$7M
Series DDec 2014$28.5M
Series CJun 2013$20M
Venture RoundOct 2012$8.1M
Venture RoundJan 2012$20M
Series BJul 2009$30M
$193.6M
Co-investors: Robert Garland (New Enterprise Associates (NEA)), Matthew McAviney (New Enterprise Associates (NEA)), David Mott (Mott Family Capital)
Vera Therapeutics
Series CJan 2021$80M
Venture RoundSep 2019$34M
$114M
Co-investors: Krishna Yeshwant (GV), Maha Katabi (Sofinnova Investments), Kurt von Emster (Abingworth)
Neuron23
Series ADec 2020$33.5M
Series BDec 2020$80M
$113.5M
Kyverna Therapeutics
Series AJan 2020$25M
$25M
Tmunity Therapeutics
Series BOct 2019$75M
Series AApr 2018$35M
$110M
Co-investors: Jorge Conde (Andreessen Horowitz)
ARMO BioSciences
Series CAug 2017$67M
Series CFeb 2016$50M
Series BMay 2014$30M
Series ANov 2013$20M
$167M
Co-investors: Eric Moessinger (NanoDimension)